Yomiuri: Kao to Launch New Premium Skincare Product From Its Kanebo Brand to Boost Sales in Asia

Dow Jones
2025/11/04
 

By Yukiho Takaichi

Yomiuri Shimbun Staff Writer

 

Kao Corp. has announced that it will launch a new toner from its flagship cosmetics brand Kanebo in January or later. The company aims to strengthen its premium skincare line in the growing Asian market.

The toner, called Kanebo Generating Essentials, incorporates a unique moisturizing ingredient inspired by vernix caseosa -- the protective substance covering a baby's skin in the womb -- that has been refined into a micro-sized formulation. The toner is designed to quickly absorb into the skin, giving it a plump but firm feel.

The same ingredient is also included in Kanebo's face cream, which was launched in September. Kao positions the new toner, priced at 13,200 yen including tax, as its flagship product to be used with the face cream, the company said Friday.

Kanebo is one of six brands Kao is focusing on for international expansion, with a goal to grow its sales by 60% by 2027 compared to 2024.

In Thailand, where the cosmetics market is expanding and where Kao has an established logistics and sales network, the company plans to increase sales revenue by 150%. The brand is working to increase its market penetration through advertising campaigns featuring popular local actors and events at which people can try the products.

Kao's cosmetics business, including Kanebo, posted an operating loss of 3.7 billion yen for the fiscal year that ended December 2024, making securing profitability a key challenge.

In the high-end cosmetics market in Asia, France's L'Oreal and Japan's Shiseido are strong players. Kao plans to enhance Kanebo's competitiveness by expanding its product lineup.

----

This article is from The Yomiuri Shimbun. Neither Dow Jones Newswires, MarketWatch, Barron's nor The Wall Street Journal were involved in the creation of this content.

YDN-M0000155535-1

 

(END) Dow Jones Newswires

November 04, 2025 03:07 ET (08:07 GMT)

Copyright (c) 2025 The Yomiuri Shimbun

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10